These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2202921)

  • 1. Comparison of urinary tract infection in calcium oxalate and calcium phosphate stone formers.
    Gault MH; Paul MD; Longerich L
    Nephron; 1990; 55(4):408-13. PubMed ID: 2202921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between urinary tract infections and stone composition in renal stone formers.
    Holmgren K; Danielson BG; Fellström B; Ljunghall S; Niklasson F; Wikström B
    Scand J Urol Nephrol; 1989; 23(2):131-6. PubMed ID: 2667113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urinary tract infection on disintegration of calcium-containing stones.
    Sarica K; Küpeli B; Soygür T; Türkölmez K; Göğüş O
    Urol Int; 1996; 57(3):188-91. PubMed ID: 8912450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of season, age, and sex on renal stone formation in South Australia.
    Baker PW; Coyle P; Bais R; Rofe AM
    Med J Aust; 1993 Sep; 159(6):390-2. PubMed ID: 8377690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
    Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of patients with staghorn calculi in our experience.
    Akagashi K; Tanda H; Kato S; Ohnishi S; Nakajima H; Nanbu A; Nitta T; Koroku M; Sato Y; Hanzawa T
    Int J Urol; 2004 May; 11(5):276-81. PubMed ID: 15147542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation.
    Amimanan P; Tavichakorntrakool R; Fong-Ngern K; Sribenjalux P; Lulitanond A; Prasongwatana V; Wongkham C; Boonsiri P; Umka Welbat J; Thongboonkerd V
    Sci Rep; 2017 Jun; 7(1):2953. PubMed ID: 28592876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of phosphate in calcium oxalate renal stones.
    Ohman S; Larsson L; Tiselius HG
    Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():59-63. PubMed ID: 1536527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and bacteriological study of urinary calculi.
    Sohshang HL; Singh MA; Singh NG; Singh SR
    J Commun Dis; 2000 Sep; 32(3):216-21. PubMed ID: 11407009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum biochemical metabolic panel with stone composition.
    Moreira DM; Friedlander JI; Carons A; Hartman C; Leavitt DA; Smith AD; Okeke Z
    Int J Urol; 2015 Feb; 22(2):195-9. PubMed ID: 25257446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of frequency, age, sex, stone weight and composition in 15,624 stones: comparison of resutls for 1980 to 1983 and 1995 to 1998.
    Gault MH; Chafe L
    J Urol; 2000 Aug; 164(2):302-7. PubMed ID: 10893570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.